An mRNA vaccine that works on all types of cancer has shown promising results in mice, Gamaleya Center director Alexander Gintsburg said in a June 6 interview with Gazeta.ru.
The drug is “being created based on mRNA technologies like the Pfizer and Moderna COVID-19 vaccines”, Gintsburg told the outlet, adding that his institute has its own mRNA platform that doesn’t rely on Western patents. The genetic vaccine will be custom-fit to each individual patient based on the results of tumor biopsies.
When asked about the vaccine’s safety, Gamaleya’s director said that the benefits of mRNA “therapeutic” vaccines outweigh the potential risks—but that the same cannot be said of “preventative” mRNA drugs.
Hellbound and Down 